Biosimilar drug by Mylan, Biocon gets USFDA approval Industry-The Economic Times — December 3, 2017 comments off Biosimilar drugs are identical copy of highly complex biologic drugs that claim to have the same efficacy as that off the innovator’s version.
Biosimilar drugs are identical copy of highly complex biologic drugs that claim to have the same efficacy as that off the innovator’s version.